Stonepine Capital Management, LLC Adamas Pharmaceuticals, Inc. Transaction History

Stonepine Capital Management, LLC

$110 Billion
Q2 2024

Shares

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 14, 2022	SELL	N/A	-3,914,938 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	N/A	1,220,643 Added 45.3%	3,914,938 $19.2 Million
Q2 2021 Aug 16, 2021	SELL	N/A	-723,984 Reduced 21.18%	2,694,295 $14.2 Million
Q1 2021 May 14, 2021	BUY	N/A	2,609,848 Added 322.83%	3,418,279 $16.4 Million
Q4 2020 Feb 12, 2021	BUY	N/A	150,964 Added 22.96%	808,431 $3.5 Million
Q3 2020 Nov 13, 2020	SELL	N/A	-100,237 Reduced 13.23%	657,467 $2.71 Million
Q2 2020 Aug 13, 2020	SELL	N/A	-405,172 Reduced 34.84%	757,704 $1.94 Million
Q1 2020 May 14, 2020	SELL	N/A	-1,078,363 Reduced 48.11%	1,162,876 $3.36 Million
Q4 2019 Feb 13, 2020	BUY	N/A	1,490,227 Added 198.43%	2,241,239 $8.49 Million
Q3 2019 Nov 13, 2019	SELL	N/A	-672,566 Reduced 47.24%	751,012 $3.84 Million
Q2 2019 Aug 13, 2019	BUY	N/A	439,249 Added 44.62%	1,423,578 $8.83 Million
Q1 2019 May 14, 2019	BUY	N/A	984,329 New	984,329 $7 Million

About Adamas Pharmaceuticals, Inc.

Ticker ADMS
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,408,100
Market Cap $376M

More about ADMS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonepine Capital Management, LLC with notifications on news.